Leslie's, Inc.
Leslie's, Inc. (LESL) Financial Performance & Income Statement Overview
Analyze Leslie's, Inc. (LESL) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Leslie's, Inc. (LESL) Income Statement & Financial Overview
Analyze Leslie's, Inc.’s LESL earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $177.13M | $175.23M | $397.86M | $569.64M |
| Cost of Revenue | $133.19M | $127.51M | $254.65M | $340.80M |
| Gross Profit | $43.95M | $47.72M | $143.21M | $228.84M |
| Gross Profit Ratio | $0.25 | $0.27 | $0.36 | $0.40 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $92.33M | $87.42M | $116.79M | $131.15M |
| Operating Expenses | $92.33M | $87.42M | $116.79M | $131.15M |
| Total Costs & Expenses | $225.51M | $214.93M | $371.44M | $471.94M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $15.90M | $15.76M | $17.02M | $18.16M |
| Depreciation & Amortization | $8.27M | $8.24M | -$1000.00 | $8.25M |
| EBITDA | -$40.11M | -$31.46M | $26.42M | $105.94M |
| EBITDA Ratio | -$0.23 | -$0.18 | $0.07 | $0.19 |
| Operating Income | -$48.38M | -$39.70M | $26.42M | $97.69M |
| Operating Income Ratio | -$0.27 | -$0.23 | $0.07 | $0.17 |
| Other Income/Expenses (Net) | -$15.90M | -$15.76M | -$17.02M | -$18.16M |
| Income Before Tax | -$64.28M | -$55.46M | $9.40M | $79.54M |
| Income Before Tax Ratio | -$0.36 | -$0.32 | $0.02 | $0.14 |
| Income Tax Expense | -$12.96M | -$10.90M | $19.33M | $18.89M |
| Net Income | -$51.32M | -$44.56M | -$9.92M | $60.65M |
| Net Income Ratio | -$0.29 | -$0.25 | -$0.02 | $0.11 |
| EPS | -$0.28 | -$0.24 | -$0.05 | $0.33 |
| Diluted EPS | -$0.28 | -$0.24 | -$0.05 | $0.33 |
| Weighted Avg Shares Outstanding | $185.26M | $185.02M | $184.94M | $184.83M |
| Weighted Avg Shares Outstanding (Diluted) | $185.26M | $185.02M | $184.94M | $184.86M |
Over the past four quarters, Leslie's, Inc. demonstrated steady revenue growth, increasing from $569.64M in Q3 2024 to $177.13M in Q2 2025. Operating income reached -$48.38M in Q2 2025, maintaining a consistent -27% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$40.11M, reflecting operational efficiency. Net income dropped to -$51.32M, with EPS at -$0.28. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan